#USA #California #LYNX #Norlase #Ophthalmoscope

Introduction of LYNX™

Norlase, a leading global manufacturer of ophthalmic lasers, has made a significant breakthrough in the field of ophthalmology with the launch of the LYNX™, the world’s first laser indirect ophthalmoscope featuring integrated pattern scanning technology. This innovative device has recently received FDA 510(k) clearance and CE marking, which marks a crucial advancement in ophthalmologic devices.

What Sets LYNX™ Apart?

Unveiled on January 27, 2025, in both Ballerup, Denmark, and Redwood City, California, the LYNX™ presents an exceptional solution for eye surgeons by eliminating the need for cumbersome external laser sources. This device is powered by a battery, offering unparalleled portability that allows medical professionals to conduct procedures in a variety of settings, enhancing their flexibility and efficiency.

Before this innovation, the demand for pattern scanning indirect ophthalmoscopes had been growing ever since the advent of pattern laser technology over 15 years ago. Oliver Hvidt, CEO and co-founder of Norlase, emphasized the need for speed and efficiency in ophthalmologic practices today, saying, "The LYNX is finally here to address those demands."

Enhanced Workflow for Surgeons

Surgeons will benefit from the ergonomic head-mounted design of the LYNX™ that integrates the laser and scanning module. This design allows ophthalmologists to move freely during procedures, which significantly reduces strain and enhances the quality of patient interaction time.

Dr. Daniel Diaz from the Retina Consultants in Miami highlighted the device’s impact, stating, “This innovative equipment harmonizes the speed of pattern laser technology with unmatched portability and comfort, setting a new standard for indirect laser procedures.” The LYNX™ offers a range of pattern options including grids from 2x2 to 5x5, along with triple arcs and circles to meet various procedural needs.

User-Centric Features

Some of the standout features of the LYNX™ include:

• - Full integration of laser, scanner, and application systems in a lightweight head-mounted device.
• - Battery-powered operation to ensure portability and procedural flexibility.
• - A comprehensive array of scan pattern options to facilitate a range of treatments.
• - innovative simpleCLEAR safety filters for improved visualization.
• - Multilingual voice control for ease of use.

Commitment to Innovation

The launch of the LYNX™ marks the fourth product introduction by Norlase in the last five years, showcasing the company's commitment to revolutionizing ophthalmology. By continuously striving for innovation, Norlase aims to significantly improve practitioners' efficiency, patient care, and overall comfort in ophthalmology around the globe.

Norlase’s product lineup already includes other groundbreaking innovations such as the LEAF laser photocoagulator, the integrated green laser known as LION, and the ECHO, the first ultraportable scanning laser worldwide. With the introduction of the LYNX™, Norlase reaffirms its vision of making cutting-edge laser technology available to ophthalmologists everywhere.

For more information on Norlase and its transformative products, visit norlase.com.